Description
Description
Primobol is one of the best known steroids manufactured in Thailand. The manufacturer is British Dragon Pharmaceuticals. The active ingredient of the drug is Metenolone Enanthate. In short, it has a high anabolic coefficient, along with a reduced androgenic value. These properties make the product virtually analogous to nandrolone and testosterone enanthate. The preparation is well suited for the reduction of lean muscle mass. It does not lead to weight gain, but only improves the quality of the weight achieved.
At the same time, it also increases the strength of athletes, making training easier and simpler. Athletes have also found that the product has a positive effect on ligaments and joints, eliminating pain and crunch and improving overall well-being.
Description of Primobol
The active ingredient of the product was invented in the 1960s. The preparation was developed specifically for use in sports and is therefore different from many other drugs, as most steroids were developed for veterinary use. For this reason, preparations based on this substance spread very quickly through the chains of sports pharmacies and gained the trust of millions of customers. The years have passed, but as strange as it may sound, preparations based on metenolone anthate have not lost their popularity. The structure of the active substance molecule is that of a modified dihydrotestosterone, which does not cause aromatisation. This is also the reason why there are hardly any side effects when using this drug. But like every rule, this one has its exceptions. For example, overdose and misuse of the preparation can cause side effects. The effects of this preparation allow us to say that it is a mild steroid. It can be used both by people who have some experience with steroids and by those who have never used it before. Women can also use it safely (but the dose should be moderate). Another advantage of the product is that it does not inhibit the synthesis of natural testosterone.
Reviews
There are no reviews yet.